Frank McCormick, Chairman of Oncology at BridgeBio Pharma, Inc. (BBIO), sold 16,250 shares at $35.74 ($581K) on 2019-12-30, disclosed to the SEC on 2019-12-31.
Open-market sale of $581k BBIO by Chairman of Oncology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBIO | SELL | 2025-09-08 | $7.9M | — | Filing → |
| BBIO | SELL | 2025-06-26 | $4.4M | — | Filing → |
| BBIO | SELL | 2023-12-28 | $4.2M | — | Filing → |